Enhancing Juvenile Drug Court Outcomes With Evidence-Based Practices

NCT ID: NCT01266109

Last Updated: 2013-06-18

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: PHASE2
• Total Enrollment: 172 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2007-09-30
• Study Completion Date: 2012-03-31

Brief Summary

Juvenile drug courts were developed in response to a perceived need to intervene more effectively with youth with substance abuse problems. Close collaboration between the court and substance abuse treatment provider is a defining component of the drug court model and is critical to helping youth achieve positive outcomes. Despite the proliferation of juvenile drug courts in recent years, however, evaluation of their capacity to reduce offender substance use and criminal activity has lagged. Moreover, the Institute of Medicine (IOM, 1998) and leading experts (McLellan, Carise, & Kleber, 2003) have presented a bleak picture of the nation's capacity to meet the treatment needs of substance abusing individuals. Although community-based programs provide the backbone of substance abuse treatment in the nation, their capabilities have not kept up with major scientific advances in the development and validation of evidence-based substance abuse interventions.

Building on our research findings and experience regarding juvenile drug court outcomes as well as the transport of evidence-based practices to community treatment settings, the purpose of this study is to develop and test a relatively flexible and low cost strategy for enhancing the outcomes of juvenile drug courts by integrating components of evidence-based treatments into existing substance abuse services.

Specifically, this project aims to:

Aim 1: Adapt existing intervention and training protocols from evidence-based practices (i.e., Contingency Management for adolescent substance abuse; family engagement strategies from evidence-based treatments of juvenile offenders) for integration into juvenile drug court sites.

Aim 2: Conduct a study to examine youth (e.g., substance use and criminal behavior) and system level (e.g., intervention adherence, feasibility, retention and completion rates, consumer satisfaction, cost estimates) effects of implementing the intervention protocols in juvenile drug courts.

Aim 3: Revise the intervention and training protocols in preparation for a Stage II study if findings are supportive.

Conditions

Adolescent Substance Use

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

CM-FAM

Group Type: EXPERIMENTAL

Contingency Management-Family Engagement (CM-FAM)

Intervention Type: BEHAVIORAL

Evidence-based outpatient intervention for adolescent substance use

US

Group Type: ACTIVE_COMPARATOR

Usual Services (US)

Intervention Type: OTHER

Typical community-based substance abuse treatment services

Interventions

Contingency Management-Family Engagement (CM-FAM)

Evidence-based outpatient intervention for adolescent substance use

Intervention Type: BEHAVIORAL

Usual Services (US)

Typical community-based substance abuse treatment services

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Juvenile Drug Court-involved youth
• Fluency in English

Exclusion Criteria

• None

• Minimum Eligible Age: 12 Years
• Maximum Eligible Age: 17 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

National Institute on Drug Abuse (NIDA)

NIH

Sponsor Role: collaborator

Medical University of South Carolina

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Scott W Henggeler, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Medical University of South Carolina

Locations

Medical University of South Carolina

Charleston, South Carolina, United States

Countries

United States

References

Tuerk EH, McCart MR, Henggeler SW. Collaboration in family therapy. J Clin Psychol. 2012 Feb;68(2):168-78. doi: 10.1002/jclp.21833.

Reference Type: BACKGROUND

PMID: 23616297 (View on PubMed)

Henggeler SW, McCart MR, Cunningham PB, Chapman JE. Enhancing the effectiveness of juvenile drug courts by integrating evidence-based practices. J Consult Clin Psychol. 2012 Apr;80(2):264-75. doi: 10.1037/a0027147. Epub 2012 Feb 6.

Reference Type: RESULT

PMID: 22309470 (View on PubMed)

McCart MR, Henggeler SW, Chapman JE, Cunningham PB. System-level effects of integrating a promising treatment into juvenile drug courts. J Subst Abuse Treat. 2012 Sep;43(2):231-43. doi: 10.1016/j.jsat.2011.10.030. Epub 2011 Dec 5.

Reference Type: RESULT

PMID: 22154039 (View on PubMed)

Other Identifiers

R01DA019892

Identifier Type: NIH

Identifier Source: secondary_id

View Link

019892

Identifier Type: -

Identifier Source: org_study_id